The Nu Chapter of the National Pharmacy Society presents the annual Rho Chi Lecture with Philip E. Empey, Pharm.D., Ph.D., FCCP, Associate Professor in Pharmacy and Therapeutics and Associate Director of Pharmacogenomics at Pitt/UPMC Institute for Precision Medicine.
The lecture is titled "Implementing Precision Prescribing Through Pharmacogenomics." The lecture is Wednesday, April 20, 2022 from 12-1 p.m. in PHR 3.106, and will be televised to the San Antonio Health Science Center Campus (MCD 3.516).
Dr. Philip Empey is the Associate Director for Pharmacogenomics of the Pitt/UPMC Institute for Precision Medicine and leads the PreCISE-Rx and Test2Learn teams to implement pharmacogenomics clinical, research and educational initiatives. He also directs the University of Pittsburgh - Thermo Fisher Scientific Pharamcogenomics Center of Excellence which is deploying population scale preemptive pharmagenomics testing (to more than 150,000 patients) in western Pennsylvania.
As a clinician-scientist in the Department of Pharmacy and Therapeutics, Dr. Empey conducts NIH-funded clinical and translational research aimed at understanding the mechanisms of the variability in drug response to improve medication-related outcomes in critically-ill patients.
He received his Pharm.D. from the University of Rhode Island and completed PGY1 and PGY2 residencies in Pharmacy Practice and Critical Care at the University of Kentucky. He earned a Ph.D. in Clinical Pharmaceutical Sciences at the University of Kentucky before completing postdoctoral research training at the University of Pittsburgh.